表紙
市場調查報告書

血紅素檢驗的全球市場:2018年∼2022年

Global Hemoglobin Testing Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 361429
出版日期 內容資訊 英文 133 Pages
訂單完成後即時交付
價格
Back to Top
血紅素檢驗的全球市場:2018年∼2022年 Global Hemoglobin Testing Market 2018-2022
出版日期: 2018年08月17日內容資訊: 英文 133 Pages
簡介

關於血紅素檢驗

血紅素檢驗,為了檢查血液中的紅血球的等級而實施。這個檢驗是定期檢驗的一部分,有助於對貧血、糖尿病、白血病、慢性腎臟病、甲狀腺機能低下症等症狀或疾病的診斷。

Technavio的分析師預測,從2018年到2022年之間,全球血紅素檢驗市場將以8.14%的年複合成長率成長。

本報告提供全球血紅素檢驗市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模(2017年)
  • 市場規模及預測(2017-2022年)

第6章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情形

第7章 客戶形勢

第8章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 比較:各終端用戶
  • 醫療保健中心
  • 診斷研究所
  • 其他
  • 市場機會:各終端用戶

第9章 地區形勢

  • 各地區市場區隔(2017-2022年)
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 市場機會

第10章 決策架構

第11章 成長要素與課題

  • 市場成長要素
  • 市場課題

第12章 市場趨勢

  • 居家護理設定的偏好高漲
  • POCT的的使用增加
  • 高度的測試設備的可用性
  • 老年人口的增加

第13章 業者情勢

  • 概要
  • 創造性破壞狀況

第14章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Abbott
  • Bio-Rad Laboratories
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Thermo Fisher Scientific

第15章 附錄

  • 簡稱的清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR21923

About Hemoglobin Testing

Hemoglobin testing is carried out to check the level of the red blood cells in the blood. This test is part of routine checkup and aids in diagnosing conditions or diseases such as anemia, diabetes, leukemia, chronic kidney disease, and hypothyroidism.

Technavio's analysts forecast the Global Hemoglobin Testing Market to grow at a CAGR of 8.14% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the hemoglobin testing market. To calculate the market size, the report considers the revenue generated from the retail sales of hemoglobin testing products, including instruments and consumables, and services across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Hemoglobin Testing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott, Bio-Rad Laboratories
  • Danahar
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Thermo Fisher Scientific

Market driver

  • Growing incidence of diabetes worldwide
  • For a full, detailed list, view our report

Market challenge

  • Limitations of hemoglobin testing
  • For a full, detailed list, view our report

Market trend

  • Growing preference for home care settings
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

  • Segmentation by end-user
  • Comparison by end-user
  • Healthcare centers - Market size and forecast 2017-2022
  • Diagnostic laboratories - Market size and forecast 2017-2022
  • Others - Market size and forecast 2017-2022
  • Market opportunity by end-user

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Growing preference for home care settings
  • Increasing use of POCT
  • Availability of advanced testing devices
  • Rise in elderly population

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Bio-Rad Laboratories
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Thermo Fisher Scientific

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global laboratory equipment market
  • Exhibit 02: Global laboratory equipment market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global hemoglobin testing market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global hemoglobin testing market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Customer landscape
  • Exhibit 19: End-user - Market share 2017-2022 (%)
  • Exhibit 20: Comparison by end-user
  • Exhibit 21: Healthcare centers - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 22: Healthcare centers - Year-over-year growth 2018-2022 (%)
  • Exhibit 23: Diagnostic laboratories - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 24: Diagnostic laboratories - Year-over-year growth 2018-2022 (%)
  • Exhibit 25: Others - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 26: Others - Year-over-year growth 2018-2022 (%)
  • Exhibit 27: Market opportunity by end-user
  • Exhibit 28: Global hemoglobin testing market - Market share by geography 2017-2022 (%)
  • Exhibit 29: Regional comparison
  • Exhibit 30: Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 31: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 32: Top 3 countries in Americas
  • Exhibit 33: EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 34: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 35: Top 3 countries in EMEA
  • Exhibit 36: APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 37: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 38: Top 3 countries in APAC
  • Exhibit 39: Market opportunity
  • Exhibit 40: R&D funding in diabetes 2015-2016 ($ millions)
  • Exhibit 41: Rise in the population aged 65 and above (% of total)
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendor
  • Exhibit 47: Abbott - Overview
  • Exhibit 48: Abbott - Business segments
  • Exhibit 49: Abbott - Organizational developments
  • Exhibit 50: Abbott - Geographic focus
  • Exhibit 51: Abbott - Segment focus
  • Exhibit 52: Abbott - Key offerings
  • Exhibit 53: Bio-Rad Laboratories - Overview
  • Exhibit 54: Bio-Rad Laboratories - Business segments
  • Exhibit 55: Bio-Rad Laboratories - Organizational developments
  • Exhibit 56: Bio-Rad Laboratories - Geographic focus
  • Exhibit 57: Bio-Rad Laboratories - Segment focus
  • Exhibit 58: Bio-Rad Laboratories - Key offerings
  • Exhibit 59: Danaher - Overview
  • Exhibit 60: Danaher - Business segments
  • Exhibit 61: Danaher - Organizational developments
  • Exhibit 62: Danaher - Geographic focus
  • Exhibit 63: Danaher - Segment focus
  • Exhibit 64: Danaher - Key offerings
  • Exhibit 65: EKF Diagnostics - Overview
  • Exhibit 66: EKF Diagnostics - Business segments
  • Exhibit 67: EKF Diagnostics - Organizational developments
  • Exhibit 68: EKF Diagnostics - Geographic focus
  • Exhibit 69: EKF Diagnostics - Segment focus
  • Exhibit 70: EKF Diagnostics - Key offerings
  • Exhibit 71: F. Hoffmann-La Roche - Overview
  • Exhibit 72: F. Hoffmann-La Roche - Business segments
  • Exhibit 73: F. Hoffmann-La Roche - Organizational developments
  • Exhibit 74: F. Hoffmann-La Roche - Geographic focus
  • Exhibit 75: F. Hoffmann-La Roche - Segment focus
  • Exhibit 76: F. Hoffmann-La Roche - Key offerings
  • Exhibit 77: Siemens Healthineers - Overview
  • Exhibit 78: Siemens Healthineers - Business segments
  • Exhibit 79: Siemens Healthineers - Organizational developments
  • Exhibit 80: Siemens Healthineers - Geographic focus
  • Exhibit 81: Siemens Healthineers - Segment focus
  • Exhibit 82: Siemens Healthineers - Key offerings
  • Exhibit 83: Thermo Fisher Scientific - Overview
  • Exhibit 84: Thermo Fisher Scientific - Business segments
  • Exhibit 85: Thermo Fisher Scientific - Organizational developments
  • Exhibit 86: Thermo Fisher Scientific - Geographic focus
  • Exhibit 87: Thermo Fisher Scientific - Segment focus
  • Exhibit 88: Thermo Fisher Scientific - Key offerings
Back to Top